Explore
13D/13G Activist Filings
119,218 resultsSome filings may show "N/A" for ticker if the subject is a private fund, SPAC, or unlisted security.
| Filed ↓ | Ticker | Company | Filer | Form | % Owned | Shares |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | ZYME | Zymeworks Inc. | Redmile Group, LLC | 13G/A | 4.9% | 3.7M |
| Nov 14, 2025 | ALGS | Aligos Therapeutics, Inc. | Woodline Partners LP | 13G/A | 8.7% | 468K |
| Nov 14, 2025 | CFLT | Confluent, Inc. | Point72 Asset Management, L.P. | 13G/A | 6.0% | 17.5M |
| Nov 14, 2025 | VNME | Vendome Acquisition Corp I | Vendome Acquisition Sponsor I LLC | 13G/A | 20.0% | 5.0M |
| Nov 14, 2025 | CNM | Core & Main, Inc. | Select Equity Group, L.P. | 13G/A | 5.1% | 9.7M |
| Nov 14, 2025 | REPL | Replimune Group, Inc. | Redmile Group, LLC | 13G/A | 0.7% | 536K |
| Nov 14, 2025 | EWTX | Edgewise Therapeutics, Inc. | RA Capital Management, L.P. | 13G/A | 9.9% | 10.4M |
| Nov 14, 2025 | MRSN | Mersana Therapeutics, Inc. | Schonfeld Strategic Advisors LLC | 13G | 5.5% | 274K |
| Nov 14, 2025 | CCIX | Churchill Capital Corp IX/Cayman | Fort Baker Capital Management LP | 13G/A | 9.6% | 2.8M |
| Nov 14, 2025 | ALXO | ALX Oncology Holdings Inc. | TANG CAPITAL MANAGEMENT, LLC | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | WM | Waste Management, Inc. | Gates Foundation Trust | 13G/A | 7.2% | 28.9M |
| Nov 14, 2025 | CMPX | Compass Therapeutics, Inc. | TANG CAPITAL MANAGEMENT, LLC | 13G/A | 10.0% | 17.2M |
| Nov 14, 2025 | BOLT | Bolt Biotherapeutics, Inc. | TANG CAPITAL MANAGEMENT, LLC | 13G/A | 3.5% | 67K |
| Nov 14, 2025 | EPIX | ESSA Pharma Inc. | TANG CAPITAL MANAGEMENT, LLC | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | AMPY | Amplify Energy Corp. | PERGA CAPITAL PARTNERS, LP | 13G | 6.8% | 2.8M |
| Nov 14, 2025 | KMPH | ZEVRA THERAPEUTICS, INC. | Woodline Partners LP | 13G/A | 6.2% | 3.5M |
| Nov 14, 2025 | GTE | GRAN TIERRA ENERGY INC. | Encompass Capital Advisors LLC | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | BOXL | Boxlight Corp | L1 Capital Global Opportunities Master Fund, Ltd. | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | CDRE | CADRE HOLDINGS, INC. | Warren B. Kanders | 13D | 30.9% | 13.0M |
| Nov 14, 2025 | PEW | GrabAGun Digital Holdings Inc. | Hilty Holdings, Ltd. | 13G | 8.3% | 2.5M |
| Nov 14, 2025 | PEW | GrabAGun Digital Holdings Inc. | Matthew W. Vittitow | 13G | 8.4% | 2.5M |
| Nov 14, 2025 | PEW | GrabAGun Digital Holdings Inc. | Marc A. Nemati | 13G | 8.4% | 2.5M |
| Nov 14, 2025 | NAMM | Namib Minerals | Hennessy Capital Partners VI LLC | 13G/A | 8.8% | 5.0M |
| Nov 14, 2025 | OMI | Owens & Minor, Inc. | Coliseum Capital Management, LLC | 13D | 16.9% | 13.1M |
| Nov 14, 2025 | TNGX | Tango Therapeutics, Inc. | Third Rock Ventures IV, L.P. | 13D/A | 7.0% | 9.4M |
| Nov 14, 2025 | SONO | Sonos, Inc. | Coliseum Capital Management, LLC | 13G/A | 12.4% | 14.9M |
| Nov 14, 2025 | ZETA | Zeta Global Holdings Corp. | David A. Steinberg | 13G/A | 10.3% | 24.5M |
| Nov 14, 2025 | ROAD | Construction Partners, Inc. | SunTx Capital II Management Corp. | 13G/A | 11.0% | 5.9M |
| Nov 14, 2025 | PAY | Paymentus Holdings, Inc. | Accel-KKR Holdings GP, LLC | 13G/A | 36.6% | 37.5M |
| Nov 14, 2025 | TSBX | Turnstone Biologics Corp. | Point72 Asset Management, L.P. | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | DYN | DYNE THERAPEUTICS, INC. | RA Capital Management, L.P. | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | MIRM | Mirum Pharmaceuticals, Inc. | BIOTECHNOLOGY VALUE FUND L P | 13G/A | 1.5% | 773K |
| Nov 14, 2025 | RAAQ | REAL ASSET ACQUISITI-CLASS A | Meteora Capital, LLC | 13G | 5.3% | 910K |
| Nov 14, 2025 | SI | Shoulder Innovations, Inc. | U.S. Venture Partners XII, L.P. | 13G | 8.2% | 1.7M |
| Nov 14, 2025 | HMST | Mechanics Bancorp | MALTESE CAPITAL MANAGEMENT LLC | 13G/A | 0.5% | 1.0M |
| Nov 14, 2025 | SOC | Sable Offshore Corp. | Encompass Capital Advisors LLC | 13G/A | 8.4% | 8.4M |
| Nov 14, 2025 | PEPG | PepGen Inc. | Point72 Asset Management, L.P. | 13G/A | 3.0% | 2.1M |
| Nov 14, 2025 | IPST | Heritage Distilling Holding Company, Inc. | C/M Capital Master Fund, LP | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | CCCX | Churchill Capital Corp X/Cayman | Fort Baker Capital Management LP | 13G/A | 4.1% | 1.7M |
| Nov 14, 2025 | DNTH | Dianthus Therapeutics, Inc. | RA Capital Management, L.P. | 13G/A | 9.5% | 3.9M |
| Nov 14, 2025 | MBLY | Mobileye Global Inc. | Point72 Asset Management, L.P. | 13G/A | 2.8% | 6.0M |
| Nov 14, 2025 | GHRS | GH Research PLC | Terwey Theis H | 13G/A | 2.9% | 1.8M |
| Nov 14, 2025 | ZIP | ZIPRECRUITER, INC. | DISCIPLINED GROWTH INVESTORS INC /MN | 13G/A | 5.7% | 4.2M |
| Nov 14, 2025 | RNA | Avidity Biosciences, Inc. | RA Capital Management, L.P. | 13G/A | 5.9% | 8.6M |
| Nov 14, 2025 | AZTR | Azitra, Inc. | L1 Capital Global Opportunities Master Fund, Ltd. | 13G/A | 2.6% | 273K |
| Nov 14, 2025 | SEI | SOLARIS ENERGY INFRASTRUCTURE, INC. | Encompass Capital Advisors LLC | 13G/A | 6.5% | 2.9M |
| Nov 14, 2025 | CDTX | Cidara Therapeutics, Inc. | Point72 Asset Management, L.P. | 13G/A | 6.2% | 1.6M |
| Nov 14, 2025 | AUUD | AUDDIA INC. | Cavalry Fund I LP | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | KURA | Kura Oncology, Inc. | BIOTECHNOLOGY VALUE FUND L P | 13G/A | 5.1% | 4.4M |
| Nov 14, 2025 | REPL | Replimune Group, Inc. | Point72 Asset Management, L.P. | 13G/A | 4.7% | 3.6M |